Harvard University’s endowment has grown to a record $68 billion, up $11 billion from last year, driven by a 27 percent investment return. This surge comes despite ongoing financial strain from federal funding cuts under the Trump administration, which have reduced federally sponsored research money by 20 percent in fiscal 2026. The university has faced nearly two years of legal and financial pressure, including denied international student enrollment and slashed research grants, which it has contested in court.
While Harvard’s endowment remains the world’s largest, much of it is restricted by donor intent, limiting flexibility during budget shortfalls. The university reported a modest surplus this year after an $113 million operating loss last year, aided by hiring freezes, attrition, and job cuts. Unrestricted funds for general operations remain in deficit.
Harvard’s treasurer and CFO warned that uncertainty persists due to ongoing litigation, funding declines, and lost international student revenue. The strong returns were driven by venture capital, public equities, and hedge funds, with private equity now the largest portfolio component. Harvard’s Chan School of Public Health is seeking corporate sponsors to offset grant losses.
Peer institutions like Penn and MIT also reported strong endowment growth, though Harvard’s remains the largest.
Source: New York Times Top Stories · Summarized by HeadlinesBriefing